Colin Belliveau

🔬 PSMA-PET vs MRI in Prostate Cancer for RT dose escalation. ✅ Findings: - MRI outperforms PSMA-PET for intermediate-risk PCa. - PSMA-PET may add value for high-risk patients ⚠️ Caution: PSMA-PET shows lower specificity in intermediate-risk PCa. shorturl.at/QWdeK

Randomized controlled trial of PSMA-PET image-guided intensification of salvage radiotherapy after radical prostatectomy: Which patients are most likely to benefit and other secondary analyses - @ColinBelliveau_ @chumontreal. #ASTRO24 coverage > bit.ly/3TSuGFk @RKSayyid

Role of brachytherapy for unfavorable intermediate-risk #ProstateCancer. Presentation by @cynthiamenardRO @chumontreal. #ASTRO24 written coverage by @chavarriagaj @UofT > bit.ly/3zvXRHk @ASTRO_org

PSMA-PET guided intensification of salvage radiotherapy after radical prostatectomy: a phase 2 randomized controlled trial. Presentation by Colin Belliveau, MD @chumontreal. #EAU24 written coverage by @RKSayyid @UofT > bit.ly/3vSu35D @Uroweb